Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added: Results Submitted and Revision: v3.4.2; Removed: No Results Posted and Revision: v3.4.1. The page now shows that results have been submitted and reflects the latest site revision.
    Difference
    0.4%
    Check dated 2026-02-11T02:17:06.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows a site-wide notice about a funding lapse affecting information currency and a page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:27:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display option and updated footer metadata to include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed the older entries Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T00:21:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:58:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas as the study location, improving visibility of where the trial is conducted. The footer changes remove the HHS Vulnerability Disclosure link and the older Texas Locations label.
    Difference
    0.2%
    Check dated 2025-12-23T21:05:31.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publications section now notes that entries are automatically filled from PubMed, replacing the previous wording; revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:17:32.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.